Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


NetAcquire LIS

Product Description

NetAcquire LIS was developed in conjunction with the staff in several hospitals in Ireland. The system is now installed in twenty sites with over 300 users. The system covers Haematology, Biochemistry, Immunology, Blood Gas, Microbiology, Histopathology, Cytology, Blood Transfusion and Post Mortems. It is configurable to allow clients switch certain disciplines on or off depending on needs.

NetAcquire LIS is a powerful software application that manages receiving, processing and storing of information generated by medical laboratory processes. It upholds best practices in a laboratory by providing accurate and meaningful diagnostic results and allows timely management and retrieval of data. Laboratory disciplines supported by NetAcquire LIS include haematology, biochemistry, coagulation, endocrinology, immunology, blood gas, microbiology, histology, cytology and semen analysis. The system is highly configurable and can be customized to facilitate all the needs of a particular lab environment as lab environments and practices may vary. The system can communicate will all medical laboratory analyzers and interact with other software systems such as hospital information systems (HIS).


Product NetAcquire LIS
Company Custom Software Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Custom Software Ltd
Clonanny Portarlington County Laois IRELAND

Tel: +353 45525491

Email: +353 45525491



Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!